Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathies,Age-related”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT00312351
What this trial is testing

A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Eyetech Pharmaceuticals 262
Testing effectiveness (Phase 2)Study completedNCT01926977
What this trial is testing

Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Arshad Khanani 100
Post-approval studies (Phase 4)Study completedNCT04761341
What this trial is testing

FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment

Who this might be right for
Age Related Macular Degeneration
Insel Gruppe AG, University Hospital Bern 28
Not applicableUnknownNCT00279695
What this trial is testing

Ultrasonic Evaluation of Ocular Tissues

Who this might be right for
GlaucomaTumorsAge-Related Macular Degeneration
Weill Medical College of Cornell University 150
Large-scale testing (Phase 3)Study completedNCT00637377
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Bayer 1,240
Not applicableStudy completedNCT02225119
What this trial is testing

The Focal Electro-Oculogram in Macular Disease

Who this might be right for
Macular DegenerationAge-Related Macular Degeneration
National Eye Institute (NEI) 39
Large-scale testing (Phase 3)Study completedNCT01835067
What this trial is testing

Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD

Who this might be right for
Exudative Macular DegenerationRetinal Hemorrhage
King's College Hospital NHS Trust 55
Not applicableLooking for participantsNCT06929507
What this trial is testing

Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients

Who this might be right for
Renal Function DisorderDiabetic Macular Edema (DME)Neovascular Age Related Macular Degeneration
University Hospital, Alexandroupolis 60
Post-approval studies (Phase 4)Study completedNCT01573572
What this trial is testing

Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium

Who this might be right for
Age-Related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema
Bausch & Lomb Incorporated 131
Early research (Phase 1)Active Not RecruitingNCT06817343
What this trial is testing

A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Neovascular (Wet) Age-related Macular Degeneration (AMD)
Exegenesis Bio 12
Large-scale testing (Phase 3)Study completedNCT03954626
What this trial is testing

Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD

Who this might be right for
Age-Related Macular DegenerationMacular DegenerationWet Macular Degeneration+3 more
Novartis Pharmaceuticals 14
Testing effectiveness (Phase 2)UnknownNCT00100087
What this trial is testing

Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Theragenics Corporation 30
Testing effectiveness (Phase 2)Study completedNCT00971464
What this trial is testing

Low Vision Study Comparing EV Training vs. CCTV for AMD Rehabilitation

Who this might be right for
AMD
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 10
Testing effectiveness (Phase 2)Study completedNCT01397409
What this trial is testing

Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular Degeneration
Allergan 271
Testing effectiveness (Phase 2)Study completedNCT07550504
What this trial is testing

Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNV

Who this might be right for
Age-Related Macular DegenerationBranch Retinal Vein Occlusion With Macular EdemaCentral Retinal Vein Occlusion With Macular Edema+1 more
Samsung Bioepis Co., Ltd. 30
Not applicableStudy completedNCT01876147
What this trial is testing

Visual and Functional Assessment in Low Vision Patients

Who this might be right for
Retinitis PigmentosaAge-related Macular DegenerationOptic Nerve Pathology+1 more
University of Oxford 50
Not applicableNo Longer AvailableNCT00349739
What this trial is testing

Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate

Who this might be right for
Macular Degeneration
University of Iowa
Testing effectiveness (Phase 2)Active Not RecruitingNCT04101877
What this trial is testing

The Sahlgrenska Anti-VEGF Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Vastra Gotaland Region 402
Not applicableActive Not RecruitingNCT00594672
What this trial is testing

Age-Related Eye Disease Study (AREDS) Follow-Up

Who this might be right for
Age-Related Macular DegenerationCataract
National Eye Institute (NEI) 110
Testing effectiveness (Phase 2)Study completedNCT00304954
What this trial is testing

Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
National Eye Institute (NEI) 13
Next Page